Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
Most studies have found a decrease in GLP-1 secretion in obese individuals [92], and some studies have found no difference in GLP-1 levels between obese and normal-weight controls [93]
The clinical trial data backs this up
For best results, use for at least 30 minutes
Successful long-term weight management isn't just about medicationit's about building sustainable habits that help maintain results after weight loss
While it is unlikely to become toxic, it may become sub-potent. This means the 7mg or 14mg dose you are taking might only have the strength of a much smaller dose